CDK1 and lung adenocarcinoma: This work aims to elucidate the oncogenic role of NiNPs via the CDK1/STAT3/FASN-FAM axis, propose API as a targeted intervention, and provide a scientific foundation for nanomaterial safety and lung adenocarcinoma prevention.